Q53YK7 (Q53YK7_HUMAN) Homo sapiens (Human)
Major prion protein UniProtKBInterProInteractive Modelling
253 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: P04156
It is possible new templates exist for this target since these models were created.
Available Structures
69 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Probing the N-terminal beta-sheet conversion in the crystal structure of the full-length human prio… |
Heteromer P04156; | |||||
Assess | ||||||
Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bo… |
Heteromer P04156; | |||||
Assess | ||||||
Human prion protein (PrP) fragment 119-231 (G127V M129 variant) complexed to ICSM 18 (anti-Prp ther… |
Heteromer P04156; | 1×SO4; | ||||
Assess | ||||||
Human prion protein (PrP) fragment 119-231 (G127V V129 variant) complexed to ICSM 18 (anti-Prp ther… |
Heteromer P04156; | 1×SO4; | ||||
Assess | ||||||
Structure of ICSM 18 (anti-Prp therapeutic antibody) Fab fragment complexed with human Prp fragment… |
Heteromer P04156; | 1×SO4; | ||||
Assess | ||||||
Structure of POM1 FAB fragment complexed with human PrPc Fragment 120-230 |
Heteromer P04156; | 1×NA; | ||||
Assess | ||||||
Fragment of human prion protein |
Heteromer P04156; | 3×FE; 4×CIT; | ||||
Assess | ||||||
Fragment of human prion protein |
Heteromer P04156; | |||||
Assess | ||||||
Cryo-EM structure of human PrP23-144 amyloid fibrils | homo-20-mer | |||||
Assess | ||||||
GYMLGS segment 127-132 from human prion with M129 | homo-12-mer | |||||
Assess | ||||||
GYVLGS segment 127-132 from human prion with V129 | homo-12-mer | 12×ACY; | ||||
Assess | ||||||
Structure of Type I Prion filaments from Gerstmann-Straussler-Scheinker disease | homo-10-mer | |||||
Assess | ||||||
Structure of Type II Prion filaments from Gerstmann-Straussler-Scheinker disease | homo-10-mer | |||||
Assess | ||||||
Cryo-EM structure of amyloid fibril formed by full-length human prion protein | homo-10-mer | |||||
Assess | ||||||
Human prion protein fibril, M129 variant | homo-10-mer | |||||
Assess | ||||||
IIHFGS segment 138-143 from human prion | homo-10-mer | 10×MPD; | ||||
Assess | ||||||
GAVVGG segment 119-124 from human prion | homo-8-mer | |||||
Assess | ||||||
AGAAAA segment 113-118 from human prion | homo-8-mer | 8×MLI; | ||||
Assess | ||||||
Cryo-EM structure of amyloid fibril formed by familial prion disease-related mutation E196K | homo-6-mer | |||||
Assess | ||||||
Crystal structure of the human prion protein reveals a mechanism for oligomerization | homo-2-mer | 4×CD; 2×CL; | ||||
Assess | ||||||
Human prion protein variant V129 domain swapped dimer | homo-2-mer | 2×CD; 2×CL; | ||||
Assess | ||||||
Human prion protein variant D178N with M129 | homo-2-mer | 2×CD; | ||||
Assess | ||||||
Human prion protein variant F198S with V129 | homo-2-mer | 2×CD; | ||||
Assess | ||||||
Human prion protein variant V129 domain swapped dimer | homo-2-mer | |||||
Assess | ||||||
Human prion protein variant F198S with M129 | homo-2-mer | 2×CD; | ||||
Assess | ||||||
Human prion protein variant D178N with V129 | homo-2-mer | 2×CD; 2×CL; | ||||
Assess | ||||||
Human prion protein with E219K protective polymorphism | monomer | |||||
Assess | ||||||
human prion protein mutant HuPrP(90-231, M129, V210I) | monomer | |||||
Assess | ||||||
Three dimensional structure of HuPrP(90-231 M129 Q212P) | monomer | |||||
Assess | ||||||
Solution-state NMR structure of the human prion protein | monomer | |||||
Assess | ||||||
Solution-state NMR structure of prion protein mutant V210I at neutral pH | monomer | |||||
Assess | ||||||
structure for wildtype Human prion protein (M129) | monomer | |||||
Assess | ||||||
Solution structure of the pathogenic mutant G131V of Human prion protein (91-231) | monomer | |||||
Assess | ||||||
structure for the protective mutant G127V of Human prion protein | monomer | |||||
Assess | ||||||
PrP226* - Solution-state NMR structure of truncated human prion protein | monomer | |||||
Assess | ||||||
HUMAN PRION PROTEIN 121-230 M166C/E221C | monomer | |||||
Assess | ||||||
Solution NMR structure of the V209M variant of the human prion protein (residues 90-231) | monomer | |||||
Assess | ||||||
HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231 | monomer | |||||
Assess | ||||||
NMR Studies of a Pathogenic Mutant (D178N) of the Human Prion Protein | monomer | |||||
Assess | ||||||
HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 | monomer | |||||
Assess | ||||||
Human prion protein fragment 90-230 | monomer | |||||
Assess | ||||||
Human prion protein variant R220K | monomer | |||||
Assess | ||||||
HUMAN PRION PROTEIN AT PH 7.0 | monomer | |||||
Assess | ||||||
Human prion protein variant R220K | monomer | |||||
Assess | ||||||
Human prion protein variant S170N | monomer | |||||
Assess | ||||||
HUMAN PRION PROTEIN AT PH 7.0 | monomer | |||||
Assess | ||||||
Human prion protein variant S170N | monomer | |||||
Assess | ||||||
Human prion protein fragment 121-230 | monomer | |||||
Assess | ||||||
Human prion protein variant M166V | monomer | |||||
Assess | ||||||
Human prion protein fragment 90-230 | monomer | |||||
Assess | ||||||
Human prion protein fragment 121-230 | monomer | |||||
Assess | ||||||
Human prion protein | monomer | |||||
Assess | ||||||
Human prion protein | monomer | |||||
Assess | ||||||
Human prion protein variant M166V | monomer | |||||
Assess | ||||||
Human prion protein variant V129 | monomer | |||||
Assess | ||||||
Crystal Structure of Human Prion Protein 90-231 | monomer | 3×CD; 1×CL; | ||||
Assess | ||||||
Structure of the CHR of the Prion protein in DPC Micelles | monomer | |||||
Assess | ||||||
Human prion protein 61-84 | monomer | |||||
Assess | ||||||
hPrP-173-195 solution structure | monomer | |||||
Assess | ||||||
hPrP-173-195-D178N solution structure | monomer | |||||
Assess | ||||||
hPrP180-195 structure | monomer | |||||
Assess | ||||||
Segment from the S170N mutant of the human prion protein 168-176 EYNNQNNFV | monomer | |||||
Assess | ||||||
Segment from the Y169F mutant of the human prion protein 168-176 EFSNQNNFV | monomer | |||||
Assess | ||||||
Segment from the human prion protein 168-176 EYSNQNNFV | monomer | |||||
Assess | ||||||
Human prion protein 61-68 | monomer | |||||
Assess | ||||||
Segment from the human prion protein 169-175 YSNQNNF | monomer | |||||
Assess | ||||||
Segment from Y169G mutant of the human prion protein 169-175 GSNQNNF | monomer | 1×ACT; 1×ZN; | ||||
Assess | ||||||
Prion peptide | monomer | |||||
Assess | ||||||
Prion peptide | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6fnv.1.A | monomer | 0.58 | 91.97 | |||
Assess |